VolitionRx Launches Innovative DETECSEPS Program for Sepsis Detection in France #VolitionRx #sepsis #DETECSEPS

VolitionRx Introduces Nu.Q® NETs Assay in Landmark Sepsis Detection Program in France #Paris #France #VolitionRx #Nu.Q #DETECSEPS

VolitionRx Completes $7.5 Million Pre-Payment on Convertible Promissory Note Ahead of Schedule #United_States #Henderson #Financial_Strategy #VolitionRx #Convertible_Note

VolitionRx Introduces Breakthrough Technology for Early Stage Cancer Detection at ESMO MAP Conference #None #London #VolitionRx #Early_Cancer_Detection #Capture-Seq